However, in cells with intermediate (MDA-MB-361) or low (HCC1954 and JIMT-1) SORLA expression, HER2 was also distributed intracellularly indicating that HER2 must be trafficked at least in a subset of HER2 cancers (Fig. 1c, Supplementary Fig. 1d). This evidence concerns the gene ERBB2 and cancer.